Document is current
Any future updates will be listed below
-
Authors
Cardoso, Kimberly Freitas https://orcid.org/0000-0003-0770-0723
de Souza, Lara Regina Alves
da Silva Santos, Beatriz Senra Álvares
de Carvalho, Ketyllen Reis Andrade https://orcid.org/0000-0002-9779-4470
da Silva Messias, Sarah Giarola
de Faria Gonçalves, Ana Paula
Kano, Flora Satiko
Alves, Pedro Augusto https://orcid.org/0000-0002-9659-5621
da Silva Campos, Marco Antônio
Xavier, Marcelo Pascoal
Garcia, Cristiana Couto
Russo, Remo Castro https://orcid.org/0000-0002-1715-3834
Gazzinelli, Ricardo Tostes
Costa, Érica Azevedo
da Silva Martins, Nelson Rodrigo
Miyaji, Eliane Namie
de Magalhães Vieira Machado, Alexandre
Silva Araújo, Márcio Sobreira https://orcid.org/0000-0002-7532-3360
- License Information
-
More Information
Article History
Received: 4 March 2024
Accepted: 21 November 2024
First Online: 19 December 2024
Competing interests
: None of the authors have a financial or personal relationship with others or organizations that could inappropriately influence or bias the paper’s content. K.F.C., A.V.M., M.S. S.A., K.R.A., B.S. A. S.S., S.G.S., F.S.K., P.A.A., A.P.F.G., M.A. P.X., E.A.C., N. R. S.M., R.T.G. and E.N.M. are co-inventors of the potential vaccine evaluated in this study. The application number of the patent evaluation process is BR1020220151636.
